1-芳酰基-4-取代异噁唑甲酰基氨基硫脲和环化产物的合成

酰胺基硫脲类化合物是具有杀虫、植物生长调节等活性的化合物[1],而且能在不同条件下发生环化反应生成多种具有广泛活性的杂环化合物[2,3];异噁唑类化合物同样是具有高活性的物质,特别是近年来出现许多含异噁唑基的商品化品种[4].为了寻找新的活性物质,合成了新型的酰胺基硫脲1及其在酸性条件下的环化产物2,合成路线如Scheme 1所示,其生物活性正在测试中.     

1-芳酰基-4-取代吡唑甲酰基氨基硫脲和环化产物的合成及生物活性

利用1-苯基-3-甲基-5-氯-4-吡唑甲酰基异硫氰酸酯(Ⅰ)与芳酰肼(Ⅱ)的加成反应合成了系列新的酰胺基硫脲衍生物(Ⅲ),并将Ⅲ在酸性条件下进行环化反应得到2-取代吡唑甲酰基氨基-5-芳基-1,3,4-噻二唑(Ⅳ).生物活性测定结果表明部分化合物Ⅲ和Ⅳ具有较好的除草活性.     

1-芳酰基-4-(5-芳基-2-呋喃甲酰基)氨基硫脲衍生物的合成及其生物活性

酰胺基硫脲;芳基酰肼;1-芳酰基-4-(5-芳基-2-呋喃甲酰基)氨基硫脲衍生物的合成及其生物活性     

1-脱氢松香酰基-3-芳酰胺基硫脲及其1,3,4-噻二唑类衍生物的合成及抑菌活性

脱氢松香酸;脱氢松香酰基芳酰胺基硫脲;芳基脱氢松香酰胺基噻二唑;抑菌活性     

1-烃基-5-取代氨基-4-吡唑(N-取代)甲酰胺的合成及生物活性研究

本文采用吡唑并[3,4-d]-1,3-噁嗪-6-酮衍生物(Ⅰ)与伯胺反应,合成了1-烃基-5-取代苯甲酰胺基-4-吡唑(N-取代)甲酰胺(Ⅱ);由LiAlH₄,对Ⅱ分子中2个酰胺基的选择性还原合成了1-烃基-5-取代氨基-4-吡唑(N-取代)甲酰胺(Ⅲ).共合成新化合物23个,通过¹HNMR、¹³CNMR、MS、IR等证明了它们的化学结构,初步生物活性测定表明化合物Ⅱ具有一定的抗癌活性和农药活性。     

C(2)-酰胺基-4-芳基-1,5-苯并硫氮杂的合成及抑菌活性的研究

设计合成了三类C(2)酰胺基取代的1,5-苯并硫氮杂衍生物:2-酰胺基(N-芳基)-4-芳基-1,5-苯并硫氮杂、2-酰胺基(N-烷基)-4-芳基-1,5-苯并硫氮杂和2-酰胺基(N,N-二烷基)-4-芳基-1,5-苯并硫氮杂,其结构用元素分析,IR,MS及1H NMR确证.测定了目标化合物的抑真菌活性,结果表明部分化合物对新生隐球菌具有中等强度的抑真菌活性.还研究了2-酰胺基-4-芳基-1,5-苯并硫氮杂的合成反应条件.     

N-(4-安替比林基)-N′-芳氧乙酰基硫脲的合成及其生物活性

酰基硫脲类化合物因其具有杀虫、抗病毒、抗真菌、除草及植物生长调节等广泛生物活性而倍受关注.我们曾合成一系列含氮杂环的芳酰基脲及硫脲,发现其中某些化合物具有优良的植物生长调节活性.在此基础上,本将4-氨基安替吡啉与芳氧乙酰基异硫氰酸酯反应,合成出7个新的含安替比林基的芳氧乙酰基硫脲,测试了它们的植物生长调节活性.     

N-(3-苯基-2,3,4-三唑甲酰氨基)-N＇-芳酰基硫脲及其环化产物的合成

以PEG-400为相转移催化剂,通过2-苯基-1,2,3-三唑-4-甲酰基肼与芳酰基异硫氰酸酯的加成反应,合成了系列新的酰胺基硫脲衍生物(3),3分别在酸性和碱性条件下环化制得相应的1,3,4-噻二唑衍生物和1,2,4-三唑啉-5-硫酮衍生物,并经元素分析、IR,1H NMR和MS确证结构.     

6-氯-3-吡啶甲基取代硫脲化合物的合成与生物活性

甲基吡啶;杀虫;植物生长调节活性;6-氯-3-吡啶甲基取代硫脲化合物的合成与生物活性     

O-烷基,O-芳基硫代磷酰取代硫脲和O-烷基硫代磷酰-双-取代硫脲的研究(Ⅱ)

用硫氰酸钾与硫代磷酰氯制备了硫代磷酰异硫氰基酯和二异硫氰基酯,并以其与不同胺反应,合成了硫代磷酰取代硫脲和硫代磷酰-双-取代硫脲两系列20个新的有机磷化合物,经1HNMR、IR及元素分析确定了它们的化学结构,测定了它们的生物活性。结果表明只有O-异丙基,O-(4-甲基-2-硝基苯基)-N''-萘基硫代磷酰硫脲(PD-1)具有较好的杀菌活性。     

2-芳酰氨基-5-(5-苄基四唑-2-亚甲基)-1,3,4-噻二唑的合成

1,3,4噻二唑环类衍生物具有抗菌,杀虫,除草,调节植物生长,消炎止疼等广泛的生理活性。本文在浓硫酸催化下将1-(5-苄基四唑-2-乙酰基)-4-芳酰基氨基硫脲(1)环化为2-芳酰氨基-5-(5-芳基四唑-2-亚甲基-1,3,4-噻二(2)。2 的结构经元素分析、红外、核磁振波谱以及质谱方法确定。     

N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类新化合物的合成及生物活性

以N-吡啶基吡唑甲酸和2-氨基-3-甲基苯甲酸为起始原料,经由亲核加成、环化和酰化等多步反应合成了一系列结构新颖的N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)酰胺类化合物.测试了所合成化合物的杀虫及抑菌活性,结果表明,新化合物大多化合物在200 mg·L^-1浓度下对东方粘虫(Mythimna separataWalker)具有一定的杀虫活性,尤其是N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)乙酰胺(8a)和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3-氯-2,2-二甲基丙酰胺(8e)致死率可达70%;部分化合物在50 mg·L^-1浓度下对油菜菌核病菌的抑菌活性相对较好(54.5%~63.6%),优于triadimefon和chlorantraniliprole;部分化合物如N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-3,3-二甲基丁酰胺80和N-(2-(5-(3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基)-1,3,4-噁二唑-2-基)-4-氯-6-甲基苯基)-4-氟苯甲酰胺(8h)对苹果轮纹病菌具有中等抑菌活性.值得注意的是,化合物8e的杀粘虫活性和对油菜菌核病菌的抑菌活性都较为突出,可用作新农药创制研究的新型参考结构.     

S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲的合成及其iNOS抑制活性

以2-巯基苯并咪唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并咪唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,¹HNMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,其中化合物6b,8d和8f的iNOS抑制活性与阳性对照药氨基胍相当.     

8-5’新木脂素类化合物的合成方法研究

对羟基桂皮酸甲酯和阿魏酸甲酯分别在氧化银催化下发生自由基仿生氧化偶联反应, 合成得苯并二氢呋喃环结构化合物1, 1经甲基化反应得2. 1a和1和2分别在无水碳酸钾、10%氢氧化钠水溶液等不同的碱性条件下进行反应, 获得了11个苯并二氢呋喃环开环产物, 即8-5’新木脂素类化合物3a～9b, 实现了由苯并二氢呋喃新木脂素向8-5’新木脂素的转变, 也为合成芪类化合物提供了一种新方法. C-8位上的吸电子基团如酯基的影响使苯并二氢呋喃环易在碱性条件下开环形成8-5’新木脂素类化合物．所合成化合物的结构由MS, IR, 1H NMR和13C NMR进行了表征.     

Reductive degradation of nido-1-CB8H12 into smaller-cage carborane systems via new monocarbaboranes [arachno-5-CB8H13](-) and closo-2-CB6H8

Treatment of the nido-1-CB8H12 (1) carborane with NaBH4 in THF at ambient temperature led to the isolation of the stable [arachno-5-CB8H13]- (2(-)), which was isolated as Na+[5-CB8H13]-.1.5 THF and PPh4 +[5-CB8H13]- in almost quantitative yield. Compound 2(-) underwent a boron-degradation reaction with concentrated hydrochloric acid to afford the arachno-4-CB7H13 (3) carborane in 70 % yield, whereas reaction between 2(-) and excess phenyl acetylene in refluxing THF gave the [closo-2-CB6H7]- (4-) in 66 % yield. Protonation of the Cs+4(-) salt with concentrated H2SO4 or CF3COOH in CH2Cl2 afforded a new, highly volatile 2-CB6H8 (4) carborane in 95 % yield, the deprotonation of which with Et3N in CH2Cl2 leads quantitatively to Et3NH+[2-CB6H7](-) (Et3NH+4(-)). Both compounds 4- and 4 can be deboronated through treatment with concentrated hydrochloric acid in CH2Cl2 to yield the carbahexaborane nido-2-CB5H9 (5) in 60 % yield. New compounds 2-, 3, and 4 were structurally characterised by the ab initio/GIAO/MP2/NMR method. The method gave superior results to those carried out using GIAO-HF when relating the calculated 11B NMR chemical shifts to experimental data.     

2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基丙烯腈衍生物的合成及生物活性

为了寻找生物活性良好的噻唑基丙烯腈类化合物, 利用2-[4-(2,6-二氟苯基)噻唑-2-基]乙腈(3)分别与取代氯甲酸酯4和取代苯基异氰酸酯6在碱存在下反应, 合成了8个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-烃氧基丙烯腈化合物5和7个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-取代苯胺基丙烯腈化合物7, 均为首次报道的丙烯腈类化合物. 化合物结构经1H NMR, IR, MS和元素分析表征. 初步生物活性测定结果表明, 在试验浓度下, 目标化合物均具有一定的杀虫和抑菌活性, 其中化合物5f和5h在100 mg/L浓度下对炭疽病菌的抑制率达95%; 化合物5g和7d在250 mg/L浓度下对棉红蜘蛛的致死率达85%.     

Theoretical and UV spectral study of isomeric 1-(quinolinyl)-beta-carbolines conformations

On the basis of beta-carboline (1) and 1-(quinolin-2'-yl)-beta-carboline (3) alpha- and t-band energies differences (Delta(alpha,t)) a equilibrium conformations of 1-(quinolin-4'(5'-8')-yl)-beta-carbolines (4-8) in solution have been estimated. Furthermore, as an example of model compounds 1-(alpha'-naphtyl)-beta-carboline (MC1) and 1-(beta'-naphtyl)-beta-carboline (MC2) and also 5 and 6 by molecular mechanics (mm+), semi-empirical (AM1) and none empirical (RHF/6-31G(d)) methods a computations of internal rotation of quinoline fragment around single bond have been performed. It was found that the greater bathochromic shift of the long-wavelength band maxima of 1, in the case of 3 (Deltalambda(max)=39 nm) relatively to 6, 7 (Deltalambda(max)=17+/-2 nm) and 4, 5, 8 (Deltalambda(max)=9+/-1 nm) caused by coplanarity of the molecule 3. Also, from experimental and theoretical investigations a less dihedral angle between beta-carboline and quinoline nucleous for 6, and 7 than 4, 5 and 8 owing to steric and electronic interactions have been found.     

Synthesis of potential metabolites of the brain imaging agents methyl (1R,2S,3S,5S)-3-(4-Iodophenyl)-8-alkyl-8-azabicyclo[3.2.1]octane-2-carboxylate

The synthesis of potential hydroxy metabolites of the brain imaging agents methyl (1R,2S,3S,5S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate and methyl (1R,2S,3S,5S)-3-(4-iodophenyl)-8-(3-fluoropropyl)-8-azabicyclo[3.2.1]octane-2-carboxylate are reported. The nitration of iodophenyltropanes 1 or 2 with nitronium tetrafluoroborate afforded the nitro compounds 3 or 4 which were reduced with iron powder to the corresponding amino compounds 5 and 6 . The final hydroxylated products 7 and 8 were obtained via a modified Sandmeyer reaction.     

Novel products from oxidation of the norditerpenoid alkaloid pseudaconine with HIO4.

Oxidation of pseudaconine 8, a norditerpenoid alkaloid, with HIO4 led to a series of novel interesting products, depending greatly on reaction medium and work-up conditions. Treatment of 8 in MeOH-H2O (1:1) with NaIO4 gave compounds 10 and 11, but compound 12 was obtained quantitatively when the final reaction solution was alkalized with conc. NH4OH. The imine 12 was also obtained in 100% yield by treating 8 in 5% HCl solution with NaIO4 followed by alkalizing the reaction products to pH>9 with conc. NH4OH. When the work up pH was 7-8, only N,O-mixed acetal-ketal 13 was formed in 96% yield, which was converted quantitatively to 12 by further alkalizing. When the reaction mixture was alkalized to pH 7-8 with Na2CO3, a hemiacetalketal 14 was afforded quantitatively, which was converted to 15 in 87% yield by further treatment with Na2CO3 or 5% NaOH methanol. Compound 15 could be converted back to 14 by treatment with 10% HCl solution. Acetylation of the imine 12 gave the compounds 16 and 17 in 15% and 19% yields, respectively. All of the new compounds were isolated and fully characterized.     

New palladium(II)-(eta(3/5)- or eta1-indenyl) and dipalladium(I)-(mu,eta3-indenyl) complexes

Reaction of the dimeric species [(eta3-Ind)Pd(mu-Cl)]2 (1) (Ind = indenyl) with NEt3 gives the complex (eta(3-5)-Ind)Pd(NEt3)Cl (3), whereas the analogous reactions with BnNH2 (Bn = PhCH2) or pyridine (py) afford the complexes trans-L2Pd(eta1-Ind)Cl (L = BnNH2 (4), py (5)). Similarly, the one-pot reaction of 1 with a mixture of BnNH2 and the phosphine ligands PR3 gives the mixed-ligand, amino and phosphine species (PR3)(BnNH2)Pd(eta1-Ind)Cl (R = Cy (6a), Ph (6b)); the latter complexes can also be prepared by addition of BnNH2 to (eta(3-5)-Ind)Pd(PR3)Cl (R = Cy (2a), Ph (2b)). Complexes 6 undergo a gradual decomposition in solution to generate the dinuclear Pd(I) compounds (mu,eta3-Ind)(mu-Cl)Pd2(PR3)2 (R = Cy (7a), Ph (7b)) and the Pd(II) compounds (BnNH2)(PR3)PdCl2 (R = Cy (8a), Ph (8b)), along with 1,1'-biindene. The formation of 7 is proposed to proceed by a comproportionation reaction between in situ-generated Pd(II) and Pd0 intermediates. Interestingly, the reverse of this reaction, disproportionation, also occurs spontaneously to give 2. All new compounds have been characterized by NMR spectroscopy and, in the case of 3, 4, 5, 6a, 7a, 7b, and 8a, by X-ray crystallography.